申请人:FORMA Therapeutics, Inc.
公开号:US20190127347A1
公开(公告)日:2019-05-02
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula I:
wherein W, X, Y, Z, R
1
, R
2
, R
5
, and R
8
are as described herein.